CD36 and diabetes mellitus: Starting the session, L.F. Lincz (Calvary Mater Newcastle Hospital, NSW, Australia) described that elevated plasma levels of the fatty acid transporter, CD36, (mainly on the surface of erythrocyte derived microparticles), constitute a better biomarker for type 2 diabetes mellitus than circulating CD36 protein concentration.